Equity Capital Markets

Company · CIK 1799448

Aligos Therapeutics, Inc.

CIK1799448 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
ListedALGS (Nasdaq)
First annual or quarterly report2020-11-25

Offerings

6 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-286168
ShelfEffective
 2025-03-272025-04-032
333-283041
ShelfEffective
 2024-11-062024-11-182
333-275636
ShelfEffective
 2023-11-172023-11-272
333-260774
ShelfEffective
 2021-11-042021-11-192
333-257466
Registered companyFinal prospectus
 2021-06-282021-07-013
333-249077
IPOFinal prospectus
 2020-09-252020-10-194

Filings

17
FiledFilingRegistrationAccession
2025-04-03EFFECTDeclared effective 333-2861689999999995-25-000975
2025-03-27S-3Shelf registered 333-2861680001193125-25-065499
2024-11-18EFFECTDeclared effective 333-2830419999999995-24-003508
2024-11-06S-3Shelf registered 333-2830410001193125-24-252199
2023-11-27EFFECTDeclared effective 333-2756369999999995-23-003451
2023-11-17S-3Shelf registered 333-2756360001193125-23-279833
2021-11-19EFFECTDeclared effective 333-2607749999999995-21-004423
2021-11-04S-3Shelf registered 333-2607740001193125-21-320316
2021-07-01424B4Final prospectus 333-2574660001193125-21-206345
2021-06-30EFFECTDeclared effective 333-2574669999999995-21-002615
2021-06-28S-1Registration filed 333-2574660001193125-21-201893
2021-06-04DRSDraft made public 377-049700000950123-21-007570
2020-10-19424B4Final prospectus 333-2490770001193125-20-272151
2020-10-15EFFECTDeclared effective 333-2490779999999995-20-002863
2020-10-09S-1/AAmendment 333-2490770001193125-20-267346
2020-09-25S-1Registration filed 333-2490770001193125-20-254760
2020-08-26DRSDraft made public 377-034560000950123-20-009341

All filings of this company · CSV